Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children
- PMID: 38064012
- PMCID: PMC10828005
- DOI: 10.1007/s12519-023-00777-9
Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children
Erratum in
-
Correction to: Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children.World J Pediatr. 2024 Feb 25. doi: 10.1007/s12519-023-00792-w. Online ahead of print. World J Pediatr. 2024. PMID: 38402517 No abstract available.
Abstract
Background: Respiratory syncytial virus (RSV) is the leading global cause of respiratory infections and is responsible for about 3 million hospitalizations and more than 100,000 deaths annually in children younger than 5 years, representing a major global healthcare burden. There is a great unmet need for new agents and universal strategies to prevent RSV infections in early life. A multidisciplinary consensus development group comprising experts in epidemiology, infectious diseases, respiratory medicine, and methodology aims to develop the current consensus to address clinical issues of RSV infections in children.
Data sources: The evidence searches and reviews were conducted using electronic databases, including PubMed, Embase, Web of Science, and the Cochrane Library, using variations in terms for "respiratory syncytial virus", "RSV", "lower respiratory tract infection", "bronchiolitis", "acute", "viral pneumonia", "neonatal", "infant" "children", and "pediatric".
Results: Evidence-based recommendations regarding diagnosis, treatment, and prevention were proposed with a high degree of consensus. Although supportive care remains the cornerstone for the management of RSV infections, new monoclonal antibodies, vaccines, drug therapies, and viral surveillance techniques are being rolled out.
Conclusions: This consensus, based on international and national scientific evidence, reinforces the current recommendations and integrates the recent advances for optimal care and prevention of RSV infections. Further improvements in the management of RSV infections will require generating the highest quality of evidence through rigorously designed studies that possess little bias and sufficient capacity to identify clinically meaningful end points.
Keywords: Consensus prevention; Respiratory syncytial virus; Treatment.
© 2023. The Author(s).
Conflict of interest statement
Author Zhi-Min Chen is a member of the Editorial Board for
Similar articles
-
Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study.Ital J Pediatr. 2024 Mar 7;50(1):45. doi: 10.1186/s13052-024-01617-w. Ital J Pediatr. 2024. PMID: 38454523 Free PMC article.
-
Respiratory Syncytial Virus is the Most Common Causative Agent of Viral Bronchiolitis in Young Children: An Updated Review.Curr Pediatr Rev. 2023;19(2):139-149. doi: 10.2174/1573396318666220810161945. Curr Pediatr Rev. 2023. PMID: 35950255 Review.
-
RSV disease in infants and young children: Can we see a brighter future?Hum Vaccin Immunother. 2022 Nov 30;18(4):2079322. doi: 10.1080/21645515.2022.2079322. Epub 2022 Jun 20. Hum Vaccin Immunother. 2022. PMID: 35724340 Free PMC article.
-
Epidemiology and prevention of respiratory syncytial virus infections in children in Italy.Ital J Pediatr. 2021 Oct 2;47(1):198. doi: 10.1186/s13052-021-01148-8. Ital J Pediatr. 2021. PMID: 34600591 Free PMC article. Review.
-
RSV associated hospitalizations in children in Karachi, Pakistan: Implications for vaccine prevention strategies.J Med Virol. 2017 Jul;89(7):1151-1157. doi: 10.1002/jmv.24768. Epub 2017 Feb 24. J Med Virol. 2017. PMID: 28092107 Free PMC article.
References
-
- Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. The Lancet. 2022;399:2047–2064. doi: 10.1016/S0140-6736(22)00478-0. - DOI - PMC - PubMed
-
- Shi T, McAllister DA, O’Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. The Lancet. 2017;390:946–958. doi: 10.1016/S0140-6736(17)30938-8. - DOI - PMC - PubMed
-
- Bardsley M, Morbey RA, Hughes HE, Beck CR, Watson CH, Zhao H, et al. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study. Lancet Infect Dis. 2023;23:56–66. doi: 10.1016/S1473-3099(22)00525-4. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical